Common Stock, Shares, Outstanding of BIOADAPTIVES, INC. from 30 Sep 2013 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
BIOADAPTIVES, INC. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 30 Sep 2013 to 30 Sep 2025.
  • BIOADAPTIVES, INC. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 10,938,725, a 99% decline year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

BIOADAPTIVES, INC. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 10,938,725 -1,220,790,249 -99% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 9,948,725 -1,221,780,249 -99% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 9,048,659 -1,145,721,982 -99% 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 8,215,426 +2,243,698 +38% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q3 2024 1,231,728,974 +455,254,951 +59% 30 Sep 2024 10-Q 19 Nov 2024 2024 Q3
Q2 2024 1,231,728,974 +655,254,951 +114% 30 Jun 2024 10-Q 19 Aug 2024 2024 Q2
Q1 2024 1,154,770,641 +769,843,359 +200% 31 Mar 2024 10-Q 17 May 2024 2024 Q1
Q4 2023 5,971,728 -246,583,037 -98% 31 Dec 2023 10-K 15 Apr 2025 2024 FY
Q3 2023 776,474,023 +725,654,243 +1428% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 576,474,023 +499,016,540 +644% 30 Jun 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 384,927,282 +334,107,502 +657% 31 Mar 2023 10-Q 12 May 2023 2023 Q1
Q4 2022 252,554,765 +201,734,985 +397% 31 Dec 2022 10-K 10 Apr 2024 2023 FY
Q3 2022 50,819,780 +15,019,735 +42% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 77,457,483 +44,425,058 +134% 30 Jun 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 50,819,780 +17,787,355 +54% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 50,819,780 +29,990,228 +144% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 35,800,045 +16,214,274 +83% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 33,032,425 +14,456,046 +78% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 33,032,425 +14,456,046 +78% 31 Mar 2021 10-Q 14 May 2021 2021 Q1
Q4 2020 20,829,552 +2,253,173 +12% 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q3 2020 19,585,771 +756,662 +4% 30 Sep 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 18,576,379 +480,210 +2.7% 30 Jun 2020 10-Q 13 Aug 2020 2020 Q2
Q1 2020 18,576,379 31 Mar 2020 10-Q/A 11 Jun 2020 2020 Q1
Q4 2019 18,576,379 +480,210 +2.7% 31 Dec 2019 10-K 30 Mar 2021 2020 FY
Q3 2019 18,829,109 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 18,096,169 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q4 2018 18,096,169 31 Dec 2018 10-K/A 12 May 2020 2019 FY
Q3 2016 14,180,456 +1,444,020 +11% 30 Sep 2016 10-Q 18 Nov 2016 2016 Q3
Q2 2016 14,180,456 +1,444,020 +11% 30 Jun 2016 10-Q 18 Aug 2016 2016 Q2
Q1 2016 14,180,456 +1,444,020 +11% 31 Mar 2016 10-Q 23 May 2016 2016 Q1
Q4 2015 12,736,436 +100,000 +0.79% 31 Dec 2015 10-Q 18 Nov 2016 2016 Q3
Q3 2015 12,736,436 +100,000 +0.79% 30 Sep 2015 10-Q 23 Nov 2015 2015 Q3
Q2 2015 12,736,436 +100,000 +0.79% 30 Jun 2015 10-Q 21 Aug 2015 2015 Q2
Q1 2015 12,736,436 +650,000 +5.4% 31 Mar 2015 10-Q 20 May 2015 2015 Q1
Q4 2014 12,636,436 +594,769 +4.9% 31 Dec 2014 10-K 14 Apr 2016 2015 FY
Q3 2014 12,636,436 +2,636,436 +26% 30 Sep 2014 10-Q 14 Nov 2014 2014 Q3
Q2 2014 12,636,436 30 Jun 2014 10-Q 14 Aug 2014 2014 Q2
Q1 2014 12,086,436 31 Mar 2014 10-Q 20 May 2014 2014 Q1
Q4 2013 12,041,667 31 Dec 2013 10-K 15 Apr 2015 2014 FY
Q3 2013 10,000,000 30 Sep 2013 10-Q 21 Oct 2013 2013 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.